ADARx Pharmaceuticals, Inc. ADRX
Set alert
16.07 USD +0.31 +1.97%
As of Nov 3, 11:37 AM ET
15.00 Day range 16.46
15.00 52-week range 23.21
- YTD
- -16.95%
- 1 year
- -16.95%
- Open
- 15.78
- Prev close
- 15.76
- Mkt cap
- 1.78B
- Vol
- 132.21K
- Avg vol
- 691.66K
- EPS
- -1.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 15.00
- High
- 16.46
- Forward P/E
- -10.42
- Beta
- 0.00
- Short ratio
- 2.00
- Inst. own
- 46.02%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 18.21
- 200-d avg
- 18.21
- 1y target
- 34.25
5D chart
Signals (128)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 1:20 PM | 22 hours ago |
| MACD: Buy Signal | Nov 2, 1:15 PM | 22 hours ago |
| MACD: Sell Signal | Nov 2, 1:00 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 12:20 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 12:15 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 12:10 PM | 23 hours ago |
| MACD: Buy Signal | Nov 2, 12:10 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 10:30 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:30 AM | 1 day ago |
| MACD: Sell Signal | Nov 2, 10:30 AM | 1 day ago |
| SMA: Bullish | Nov 2, 10:25 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:20 AM | 1 day ago |
| SMA: Bullish | Nov 2, 10:05 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:55 AM | 1 day ago |
| SMA: Bullish | Nov 2, 9:35 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 day ago |
| RSI: Overbought | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 3 days ago |
Newest 20 of 128.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 34.25 +113.1% upside
Now 16.07
- Target (low)
- 32.00
- Target (mean)
- 34.25
- Target (high)
- 38.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy2
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.36348 | -0.53 – -0.25367 | 0.00 | 0.0% | 2.58M | 0.0% | 3 |
| Next quarter | -0.37861 | -0.40 – -0.36363 | 0.00 | 0.0% | 2.58M | 0.0% | 3 |
| Current year | -1.68 | -1.89 – -1.55 | 0.00 | 0.0% | 5.94M | 0.0% | 3 |
| Next year | -1.51 | -1.81 – -1.18 | -1.68 | +9.9% | 39.87M | +570.7% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | TD Cowen | Initiated | — | Buy |
| Oct 20, 2026 | JP Morgan | Initiated | — | Overweight |
| Oct 20, 2026 | UBS | Initiated | — | Buy |
| Oct 20, 2026 | Morgan Stanley | Initiated | — | Overweight |